Tricalcium phosphate/hydroxyapatite (TCP-HA) bone scaffold as potential candidate for the formation of tissue engineered bone

Indian Journal of Medical Research

Volumn 137, Issue 6, 2013, Pages 1093-1101

  Sulaiman, Shamsul Bin ^a   Keong, Tan Kok ^b   Cheng, Chen Hui ^c   Saim, Aminuddin Bin ^d   Hj Idrus, Ruszymah Bt ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b Department of Orthopedic and Traumatology ^*  (Malaysia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d Ampang Puteri Specialist Hospital Malaysia   (Malaysia)

Author keywords

Bone; Ceramics phosphate; Fibrin; Scaffold; Tissue engineering

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN FIBER; FIBRIN; HYDROXYAPATITE; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CALCIFICATION; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; GENE EXPRESSION; HISTOLOGY; IN VITRO STUDY; MICROSCOPY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPE; TISSUE ENGINEERING;

ANIMALS; ANTHRAQUINONES; BONE MARROW CELLS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CERAMICS; DURAPATITE; FIBRIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; OSTEOGENESIS; PHOSPHATES; REAL-TIME POLYMERASE CHAIN REACTION; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84879528940     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aminuddin BS, Ruszymah BHI. Tissue engineering research in developing countries, the significant and differences as compared to the developed countries. Med J Malaysia 2008; 63 (Suppl A): 47-8.
2. Ruszymah BHI, Chua KH, Mazlyzam AL, Fuzina NH, Aminuddin BS. Human serum verses animal serum in human cartilage tissue engineering. Int Med J 2003; 2: 6-7.
3. Angela Ng MH, Tan KK, Phang MY, Aziyati O, Tan GH, Isa MR, et al. Differential osteogenic activity of osteoprogenitor cells on HA and TCP/HA scaffold engineered bone. Biomed M Res 2008; 85A: 301-2.
4. Wongwitwichot P, Kaewsrichan J, Chua KH, Ruszymah BHI. Comparison of TCP and TCP/HA hybrid scaffolds for osteoinductive activity. Biomed Eng J 2010; 4: 279-85.
5. Angela Ng MH, Aminuddin BS, Tan KK, Tan GH, Isa M Ros, Fauziah O, et al. Comparison of bioengineered human bone construct from four sources of osteogenic cells. J Ortho Sci 2005; 10: 192-9.
6. Tan KK, Shamsul BS, Aminuddin BS, Tan GH, Chua KH, Angela Ng MH, et al. Bone graft substitute hydroxyapatite scaffold seeded with tissue engineered autologous osteoprogenitor cells in spinal fusion: early result in sheep as a model. Med J Malaysia 2005; 60: 53-8.
7. Boden SD, Schimandle JH, Hutton WC, Damien CJ, Benedict JJ, Baranowski C, et al. In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion. J Spinal 1997; 10: 1-11.
8. Kim HJ, Kim UJ, Kim HS, Li C, Wada M, Leisk GG, et al. Bone Tissue Engineering with Premineralized silk scaffolds. Bone 2008; 42: 1226-34.
9. Mandal BB, Kundu CC. Non-mulberry silk gland fibroin 3-D scaffold for enhanced differentiation of human mesenchymal stem cell into osteocytes. Acta Biomater 2009; 5: 2579-90.
10. Gehron-Robey P. Bone matrix proteoglycans and glycoproteins: In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego, CA, USA: Academic Press; 1996. p. 155-16.
11. Denhardt, DT, Guo X. Osteopontin: A protein with diverse functions. FASEB J 1993; 7: 1475-82.
12. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression of bone sialo protein (BSP) in developing human tissues. Calcif Tissue Int 1991; 49: 421-6.
13. Hauschka PJ, Lian Cole D, Gundberg C. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
14. Zhang Y, Ni M, Zhang M, Ratner B. Calcium Phosphate - chitosan composite scaffolds for bone tissue engineering. Tissue Eng 2003; 9: 337-45.
15. Ganss B, Kim RH, Sodek J. Bone sialoprotein. CritRev Oral Biol Med 1999; 10: 79-98.
16. Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone Sialoprotein. Proc Natl Acad Sci USA 1993; 90: 8562-5.
17. Roach HI. Why does bone matrix contain noncollagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 1994; 18: 617-28.
18. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FaSeB J 1990; 4: 3111-23.
19. Kondo H, Ohyama T, Ohya K, Kasugai S. Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/ PTHrP) receptor in bone development. J Bone Miner Res 1997; 12: 2089-97.
20. Phang MY, Angela NMH, Tan KK, Aminuddin BS, Ruszymah BHI, et al. Evaluation of suitable biodegradable scaffolds for engineered bone tissue. Medical J Malaysia 2004: 59 (Suppl B): 198-9.
21. Torigoe I, Sotome S, Tsuchiya A, Yoshii T, Maehara H, Sugata Y, et al. Bone regeneration with autologous plasma, bone marrow stromal cells, and porous b-tricalcium phosphate in nonhuman primates. Tissue Eng Part A 2009; 15: 1489-99.
22. Niehoff P, Springer IN, Afil Y, Lange A, Marget M, Roldan JC, et al. HDR brachytherapy irradiation of the jaw - as a new experimental model of radiogenic bone damage. J Craniomaxillofac Surg 2008; 36: 203-9.
23. Smucker JD, Aggarwal D, Atkinson BL, Bobst JA, Nepola JV, Fredericks DC. B2a Peptide on ceramic granules enhances posterolateral spinal fusion in rabbits compared with autograft. Spine 2008; 33: 1324-9.